In-Vitro Diagnostics Market is expected to reach USD 128.8 Billion by 2029

The In-Vitro Diagnostics Market size was valued at USD 101.8 Bn. in 2022 and the total revenue is expected to grow by 3.41 % from 2023 to 2029, reaching nearly 128.8 Bn.

In-Vitro Diagnostics (IVD) are diagnostic tests that are used to diagnose infections and disease, diagnose medical condition, and monitor drug therapies. Such tests are carried out on samples including tissues, blood, and urine.

The development of condition-specific markers and tests, the increasing importance of companion diagnostics, and point-of-care (POC) tests with multiplexing capabilities are the factors that are anticipated to provide significant growth opportunities in the upcoming years, according to primary and secondary research. For a wide range of medical and medicinal applications, manufacturers in the in-vitro diagnostics market are developing and marketing affordable kits and reagents.